636 results on '"Cutland, Clare"'
Search Results
2. High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response.
3. Consensus study on factors influencing the academic entrepreneur in a middle-income country’s university enterprise
4. Prevalence of group B Streptococcus colonisation in mother–newborn dyads in low-income and middle-income south Asian and African countries: a prospective, observational study
5. Burden of Lassa fever disease in pregnant women and children and options for prevention
6. Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review
7. ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19
8. Obstetric and neonatal outcomes in South Africa
9. Malaria is a cause of iron deficiency in African children
10. In-hospital mortality risk stratification in children aged under 5 years with pneumonia with or without pulse oximetry: A secondary analysis of the Pneumonia REsearch Partnership to Assess WHO REcommendations (PREPARE) dataset
11. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial
12. A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12–14-month-old children
13. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
14. Association between preeclampsia and HIV: a case-control study in urban South Africa
15. Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration project
16. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials
17. WHO global vaccine safety multi-country collaboration project on safety in pregnancy: Assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization
18. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
19. Knowledge and attitudes towards maternal immunization: perspectives from pregnant and non-pregnant mothers, their partners, mothers, healthcare providers, community and leaders in a selected urban setting in South Africa
20. Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial
21. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study
22. Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial
23. Rubella seroprevalence in pregnant women living with and without HIV in Soweto, South Africa
24. Prevalence and predictors of vitamin D deficiency in young African children
25. Causes of stillbirths among women from South Africa: a prospective, observational study
26. Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women : A Longitudinal Cohort Study
27. Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM 197 -Conjugate Vaccine During Pregnancy
28. Q fever: The southern African perspective
29. Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study
30. Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination
31. Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative
32. Influenza or Meningococcal Immunization During Pregnancy and Mortality in Women and Infants: A Pooled Analysis of Randomized Controlled Trials
33. Respiratory Syncytial Virus Vaccination During Pregnancy and Effects in Infants
34. Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial
35. Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials
36. Consensus study on factors influencing the academic entrepreneur in a middle-income country’s university enterprise
37. Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother–Infant Dyads: A Longitudinal Cohort Study
38. Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease
39. Estimating the burden of iron deficiency among African children
40. Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy
41. Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data
42. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data
43. Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
44. Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
45. Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date
46. COVID-19 Vaccination Hesitancy among Youths in Soweto, South Africa
47. Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial
48. Efficacy of Primary Series AZD1222 (ChAdOx1 nCoV-19) Vaccination Against SARS-CoV-2 Variants of Concern: Final Analysis of a Randomized, Placebo-controlled, Phase 1b/2 Study in South African Adults (COV005)
49. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
50. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.